| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/24/1989 | EP0316444A1 Yeast expression vector. |
| 05/24/1989 | EP0316441A1 Fruit-specific transcriptional factors |
| 05/24/1989 | EP0316425A1 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER |
| 05/24/1989 | EP0316354A1 Genes encoding antigens of m. leprae |
| 05/24/1989 | DE3737367A1 Vascular anticoagulant proteins, DNA which encode the latter, process for their preparation and their use |
| 05/24/1989 | CN1033073A Method for promoting intramolecular bond fisulfide bormation in recombinant proteins contained in denaturant solution |
| 05/24/1989 | CN1033072A Recombinant dna-derived bordetella toxin subvnit analogs |
| 05/24/1989 | CN1033070A Modified plasminogen activators |
| 05/24/1989 | CN1033008A Vaccine against e. coli septicaemia in poultry |
| 05/23/1989 | US4833233 Human serum albumin crystals and method of preparation |
| 05/23/1989 | US4833166 Growth hormone releasing hormone complementary peptides |
| 05/23/1989 | US4833127 Novel CSF and method for obtaining the same |
| 05/23/1989 | US4833085 Monoclonal antibody specific for human colon fibroblast-derived t-PA |
| 05/23/1989 | US4833080 Regulation of eucaryotic gene expression |
| 05/23/1989 | US4833074 Purified human granylocyte L1 proteins methods for their preparation, monospecific antibodies and test kits |
| 05/23/1989 | US4833072 Polypeptides, aids |
| 05/23/1989 | US4833071 Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor |
| 05/23/1989 | US4832959 Preparation of polypeptides having human γ-interferon activity |
| 05/23/1989 | US4832940 Method of locating or imaging activated T-lymphocytes with a targeting polypeptide |
| 05/23/1989 | US4832849 Liquid chromatography |
| 05/23/1989 | CA1254699A1 Renin inhibitors containing statine or derivatives thereof |
| 05/23/1989 | CA1254527A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods |
| 05/18/1989 | WO1989004491A1 Urinary assay for measuring bone resorption |
| 05/18/1989 | WO1989004489A1 Protein ligand detection using polypeptide-induced monoclonal receptors |
| 05/18/1989 | WO1989004486A1 Diagnostic methods and systems for quantifying apo ai |
| 05/18/1989 | WO1989004371A1 Plants genetically enhanced for disease resistance |
| 05/18/1989 | WO1989004370A1 Human monoclonal anti-hiv-i-antibodies |
| 05/18/1989 | WO1989004365A1 Microorganism having low acetate forming capability and its application |
| 05/18/1989 | WO1989004327A1 Human monoclonal antibody against aspergilli |
| 05/18/1989 | WO1989004326A1 Alveolar surfactant proteins |
| 05/18/1989 | WO1989004325A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum |
| 05/18/1989 | WO1989004324A1 Phosphoryled derivatives of cardiodilatine/anf peptides |
| 05/18/1989 | WO1989004323A1 Hypoglycaemic peptides |
| 05/18/1989 | WO1989004322A1 Purification by affinity binding to liposomes |
| 05/18/1989 | WO1989004302A1 Electrochemiluminescent rhenium moieties and methods |
| 05/18/1989 | WO1989004209A1 Emulsifiers |
| 05/18/1989 | WO1989004174A1 Anti-c3bi receptor (cr3) antibodies and therapeutic composition |
| 05/18/1989 | WO1989004171A1 Protein fraction with immunosuppressive activity, isolated from human seminal plasma |
| 05/18/1989 | WO1989003846A3 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same |
| 05/18/1989 | WO1989002277A3 Prophylaxis and therapy of acquired immunodeficiency syndrome |
| 05/18/1989 | DE3737917A1 Phosphorylierte derivate von cardiodilatin/anf-peptiden Phosphorylated derivatives of cardiodilatin / anf-peptides |
| 05/18/1989 | DE3737703A1 Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum Neutrophil-activating polypeptide moved to its production and its use as a drug and diagnostic use |
| 05/17/1989 | EP0316306A2 Monoclonal antibodies special for HB A1c |
| 05/17/1989 | EP0316229A1 Microorganism having low acetate forming capability, and process for production of useful substrate using same |
| 05/17/1989 | EP0316212A1 Use of nitrophenyls or anti-nitrophenyl antibodies for modification of the interaction between host-sensitive cells and a pathogenic agent |
| 05/17/1989 | EP0316170A2 Method for the identification of antigens expressed in vivo, diagnostic assays therefor and vaccines containing them |
| 05/17/1989 | EP0316115A2 Novel voctors and expression sequences for production of polypeptides |
| 05/17/1989 | EP0316068A1 Modified low molecular weight plasminogen activator and method of preparation |
| 05/17/1989 | EP0316018A2 Modification of DNA sequences |
| 05/17/1989 | EP0315968A1 Plasma and recombinant protein formulations in low ionic strength media |
| 05/17/1989 | EP0315950A2 Method of incubating cells expressing a recombinant protein |
| 05/17/1989 | EP0315683A1 Dna sequences, recombinant dna molecules and processes for producing lymphocyte function associated antigen-3 |
| 05/17/1989 | EP0315650A1 Purification of recombinant interleukin-1. |
| 05/16/1989 | US4831175 Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
| 05/16/1989 | US4831125 Digestion with restriction enzyme, cloning |
| 05/16/1989 | US4831121 Polydisperse native pseudomonas flagellar (H) antigens (FAg) and methods of producing them |
| 05/16/1989 | US4831120 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell |
| 05/16/1989 | US4831119 Blood clotting factors |
| 05/16/1989 | US4831118 Improved immunoadsorbent for isolation of coagulation proteins |
| 05/16/1989 | US4831012 Purified hemoglobin solutions and method for making same |
| 05/16/1989 | US4830965 Dna sequence contains endonuclease recognition sites and base pair attachment sites for mu bacteriophage genome |
| 05/16/1989 | US4830962 Expression vectors encoding for a dt-a fragment which use dna control sequences not native to the coding sequences but compatible to the host |
| 05/16/1989 | US4830852 Covalent-modification and having a coupling spacer containing a thioether; vaccines; chemical stability; infant protection |
| 05/16/1989 | US4830847 Radioactive proteins |
| 05/16/1989 | US4830716 With metals, oxides, hydroxides or carbonates in aqueous environment |
| 05/16/1989 | EP0228452A4 Protein purification. |
| 05/16/1989 | CA1254349A1 Synthesis of hgrf (somatocrinin) in liquid phase |
| 05/16/1989 | CA1254161A1 Herpes virus specific immunological materials and methods |
| 05/16/1989 | CA1254137A1 Mechanically sheared collagen implant material and method |
| 05/16/1989 | CA1254114A1 Displacement polynucleotide assay employing recombination protein and diagnostic kit |
| 05/11/1989 | EP0246279A4 Method for isolation of recombinant polypeptides in biologically active forms. |
| 05/11/1989 | EP0217822A4 Human metallothionein-ii promoter in mammalian expression system. |
| 05/10/1989 | EP0315574A2 Renin inhibitors |
| 05/10/1989 | EP0315519A2 Aminopimelic acid derivatives, process for their preparation and their use as medicines |
| 05/10/1989 | EP0315459A2 HIV incomplete particles and a method for production thereof |
| 05/10/1989 | EP0315456A2 Polysaccharide-modified immunoglobulins having reduced immunogenic potential or improved pharmacokinetics |
| 05/10/1989 | EP0315349A1 Phospholipase A2 inhibiting compositions and their use |
| 05/10/1989 | EP0315289A2 Cell growth inhibitory factor |
| 05/10/1989 | EP0315254A1 Protein 7B2, recombinant DNA, cDNA and mRNA, and a method of detecting the mRNA |
| 05/10/1989 | EP0315242A2 Process for purifying recombinant hepatitis antigens |
| 05/10/1989 | EP0315220A1 Method of forming a metal chelate protein conjugate |
| 05/10/1989 | EP0315188A2 Methods and materials for the preparation of metal labelled antibody solutions |
| 05/10/1989 | EP0315118A2 DNA coding for endothelin and use thereof |
| 05/10/1989 | EP0315085A2 Recombinant histidine-rich protein from Plasmodium falciparum, its synthesis and use |
| 05/10/1989 | EP0315081A2 Anti-coagulating protein PP4-x, its preparation and use |
| 05/10/1989 | EP0314866A2 Novel alkylated hormonereleasing peptides and method of treating mammals therewith |
| 05/10/1989 | EP0314862A1 Immunogenic conjugates comprising cyclosporins |
| 05/10/1989 | EP0314861A1 Labeled derivatives of cyclosporins |
| 05/10/1989 | CN1032816A Monoclonal antibodies against human interleukin-4 and hybridomas producing same |
| 05/10/1989 | CN1032795A Linear and cyclic analogues of alpha-msh fragments with extraordinary potency |
| 05/09/1989 | US4829070 Prodrug for sustained release of dopamine |
| 05/09/1989 | US4829053 Renin inhibitors |
| 05/09/1989 | US4829052 Serine protease inhibitors |
| 05/09/1989 | US4828990 Zinc or copper salt, polyethylenimine |
| 05/09/1989 | US4828989 Process for purifying a protein |
| 05/09/1989 | US4828988 Hybrid polypeptides comprising somatocrinine and alpha1 -antitrypsin, method for their production from bacterial clones and use thereof for the production of somatocrinine |
| 05/09/1989 | US4828987 Avian retrovirus-bovine growth hormone DNA |
| 05/09/1989 | US4828821 Glycoprotein, calcium salt crystal growth inhibitor |
| 05/09/1989 | CA1254000A1 Growth hormone releasing factor analogs |
| 05/09/1989 | CA1253999A1 .alpha.-AMINOBORONIC ACID PEPTIDES |